{"filing":{"accession_number":"0001933414-26-000125","cik":"0001933414","ticker":"MLYS","company_name":"Mineralys Therapeutics, Inc.","form":"8-K","filing_date":"2026-10-19","report_date":"2026-10-16","primary_document":"mlys-20261016.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000125/mlys-20261016.htm"},"events":[{"id":36126,"run_id":33308,"accession_number":"0001933414-26-000125","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of two new directors, Kristine Peterson and Lonnel Coats, to the Board effective October 19, 2026, increasing Board size from seven to nine members. While the disclosure also includes compensatory arrangements (equity grants and cash compensation), the principal disclosed action is the appointment of these individuals to director roles. This is material as board composition changes affect governance and investor assessment of the company.","company_name":"Mineralys Therapeutics, Inc.","ticker":"MLYS","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40424,"accession_number":"0001933414-26-000125","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two new directors, Kristine Peterson and Lonnel Coats, to the Board effective October 19, 2026, increasing Board size from seven to nine members. While the disclosure also includes compensatory arrangements (equity grants and cash compensation), the principal disclosed action is the appointment of these individuals to director roles. This is material as board composition changes affect governance and investor assessment of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:38:36.342175+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40424,"accession_number":"0001933414-26-000125","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two new directors, Kristine Peterson and Lonnel Coats, to the Board effective October 19, 2026, increasing Board size from seven to nine members. While the disclosure also includes compensatory arrangements (equity grants and cash compensation), the principal disclosed action is the appointment of these individuals to director roles. This is material as board composition changes affect governance and investor assessment of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:38:36.342175+00:00","company_name":"Mineralys Therapeutics, Inc.","ticker":"MLYS","filing_date":"2026-10-19"}]}